Health In Tech, Inc.
Health In Tech, Inc. Fundamental Analysis
Health In Tech, Inc. (HIT) shows weak financial fundamentals with a PE ratio of 65.28, profit margin of 3.84%, and ROE of 7.89%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.77%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -140131.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HIT's fundamental strength across five key dimensions:
Efficiency Score
WeakHIT struggles to generate sufficient returns from assets.
Valuation Score
ModerateHIT shows balanced valuation metrics.
Growth Score
WeakHIT faces weak or negative growth trends.
Financial Health Score
ExcellentHIT maintains a strong and stable balance sheet.
Profitability Score
WeakHIT struggles to sustain strong margins.
Key Financial Metrics
Is HIT Expensive or Cheap?
P/E Ratio
HIT trades at 65.28 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, HIT's PEG of -2.44 indicates potential undervaluation.
Price to Book
The market values Health In Tech, Inc. at 4.88 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 36.13 times EBITDA. This signals the market has high growth expectations.
How Well Does HIT Make Money?
Net Profit Margin
For every $100 in sales, Health In Tech, Inc. keeps $3.84 as profit after all expenses.
Operating Margin
Core operations generate 4.59 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.89 in profit for every $100 of shareholder equity.
ROA
Health In Tech, Inc. generates $5.54 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Health In Tech, Inc. generates limited operating cash flow of $-5.03T, signaling weaker underlying cash strength.
Free Cash Flow
Health In Tech, Inc. generates weak or negative free cash flow of $-5.03T, restricting financial flexibility.
FCF Per Share
Each share generates $-93449.50 in free cash annually.
FCF Yield
HIT converts -65914.71% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
65.28
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.44
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.88
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.42
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.008
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How HIT Stacks Against Its Sector Peers
| Metric | HIT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 65.28 | 34.22 | Worse (Expensive) |
| ROE | 7.89% | 1033.00% | Weak |
| Net Margin | 3.84% | -48116.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.44 | Strong (Low Leverage) |
| Current Ratio | 3.13 | 5.66 | Strong Liquidity |
| ROA | 5.54% | -288969.00% (disorted) | Weak |
HIT outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Health In Tech, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
172.42%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
578.05%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
124.20%
Industry Style: Growth, Innovation, High Beta
High Growth